台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

健亞

(4130)
可現股當沖
  • 股價
    24.20
  • 漲跌
    ▲0.30
  • 漲幅
    +1.26%
  • 成交量
    312
  • 產業
    上櫃 生技醫療類股
  • 151人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
健亞 (4130)籌碼相關-台新-前鎮 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

台新-前鎮 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2018/10/19228.7000.0029.5521,1480.17%
2018/10/18130.60130.1029.5001,1450.00%
2018/10/16130.00130.0030.0501,1400.00%
2018/10/08332.48332.0032.0001,0850.00%
2018/10/05533.94633.4432.70-11,073-0.09%
2018/10/04233.50233.5833.4501,0180.00%
2018/10/0300.00133.6533.35-11,006-0.10%
2018/10/01136.3000.0035.5019760.10%
2018/09/27535.99435.6834.9018720.11%
2018/09/18331.95331.3531.2505850.00%
2018/09/14232.50231.9031.9005650.00%
2018/09/13131.90132.0031.8505550.00%
2018/09/121232.641232.8232.5005250.00%
2018/09/10133.15134.2032.6004370.00%
2018/06/2900.00232.9032.85-21,073-0.19%
2018/06/28233.0500.0032.8021,1140.18%
2018/06/13135.4000.0034.8011,5460.06%
2018/05/29134.2000.0034.1011,5460.06%
2018/05/16237.28236.7536.5501,5270.00%
2018/05/0900.00137.0536.75-11,495-0.07%
2018/05/08236.88237.5037.5001,4860.00%
2018/05/0400.001136.0735.90-111,461-0.75%
2018/04/27135.5000.0035.7011,4270.07%
2018/04/2000.00237.8337.45-21,363-0.15%
2018/04/19238.0000.0037.6521,3770.15%
2018/04/16138.35138.1037.6501,3400.00%
2018/04/13139.20138.7537.7001,3260.00%
2018/04/12139.80239.8338.85-11,307-0.08%
2018/04/11138.8500.0039.4511,2760.08%
2018/04/1000.00341.0038.60-31,240-0.24%
2018/04/031639.94239.7539.35141,0681.31%
2018/03/31237.98238.0837.9008730.00%
2018/03/2900.00138.1537.80-1811-0.12%
2018/03/28237.88138.0037.9517590.13%
2018/03/0800.00134.1034.10-1411-0.24%
2018/03/07233.55233.7334.0004020.00%
2018/02/27132.9000.0032.9014060.25%
2018/02/26133.15133.0032.9004100.00%
2018/02/0700.001031.4030.90-10582-1.72%
2018/01/3000.00134.0533.90-1593-0.17%
2018/01/2900.00134.4034.25-1593-0.17%
2018/01/26234.30234.2534.8005930.00%
2018/01/19134.6500.0034.2516100.16%
2018/01/18134.5000.0034.2516110.16%
2018/01/17134.50234.3534.25-1626-0.16%
2018/01/16135.2500.0035.0516440.16%
2018/01/15135.25134.9534.8006100.00%
2018/01/1000.00133.6033.80-1584-0.17%
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章